Valneva SE (VALN) Change in Cash (2021 - 2026)
Valneva SE (VALN) posted Change in Cash of -$5.5 million for Q1 2026, up 86.07% sequentially from -$39.7 million in Q4 2025, and up 64.19% YoY from -$3.4 million in Q1 2025.
Valneva SE (VALN) Change in Cash (2021 - 2026) Analysis & Trends
Valneva SE has reported Change in Cash for 6 years, with the latest figure at -$5.5 million in Q1 2026.
- Quarterly Change in Cash rose 64.19% year-over-year to -$5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$53.2 million (down 102.76% YoY) and the FY2025 annual result came in at -$64.3 million, down 247.08% from the prior year.
- Change in Cash advanced to -$5.5 million in Q1 2026 per VALN's latest filing, from -$39.7 million in the prior quarter.
- Over five years, Change in Cash peaked at $88.6 billion in Q3 2023 and troughed at -$88.8 billion in Q2 2023.
- A 5-year average of -$16.9 million and a median of -$15.5 million in 2025 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 111167.64% in 2023, down 345235.54% in 2023.
- Over 5 years, Change in Cash stood at $31.7 million in 2022, then sank by 253.64% to -$48.7 million in 2023, then jumped by 121.11% to $10.3 million in 2024, then tumbled by 486.41% to -$39.7 million in 2025, then surged by 86.07% to -$5.5 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$5.5 million, -$39.7 million, and -$20.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn | 18.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.72 Mn |
| Mar 31, 2026 | -5.53 Mn |
| Dec 31, 2025 | -39.73 Mn |
| Sep 30, 2025 | -20.81 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | -15.45 Mn |
| Dec 31, 2024 | 10.28 Mn |
| Sep 30, 2024 | 28.55 Mn |
| Jun 30, 2024 | -49.61 Mn |
| Mar 31, 2024 | 55.21 Mn |
| Dec 31, 2023 | -48.72 Mn |
| Sep 30, 2023 | 88.64 Bn |
| Jun 30, 2023 | -88.76 Bn |
| Mar 31, 2023 | -34.03 Mn |
| Dec 31, 2022 | 31.71 Mn |
| Sep 30, 2022 | -79.80 Mn |
| Jun 30, 2022 | 25.72 Mn |
| Mar 31, 2022 | -39.64 Mn |
| Dec 31, 2021 | 111.05 Mn |
| Sep 30, 2021 | -96.55 Mn |